欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5065/003
药品名称Sunitinib Krka 50 mg harde capsules
活性成分
    • SUNITINIB 50.0 mg
剂型Capsule, hard
上市许可持有人Krka d.d. Novo Mesto Smarjeska Cesta 6 8501 Novo Mesto Slovenia
参考成员国 - 产品名称Netherlands (NL)
Sunitinib Krka 50 mg harde capsules
互认成员国 - 产品名称
    • Norway (NO)
      Sunitinib Krka
    • Finland (FI)
    • Poland (PL)
      Sunitinib Krka
    • Lithuania (LT)
      Sunitinib Krka 50 mg kietosios kapsulės
    • Denmark (DK)
    • Hungary (HU)
      Sunitinib Krka 50 mg kemény kapszula
    • Belgium (BE)
      Sunitinib Krka 50 mg harde capsules
    • Bulgaria (BG)
      Sunitinib KrkA
    • Iceland (IS)
      Sunitinib STADA
    • Czechia (CZ)
      Sunitinib Krka
    • Ireland (IE)
    • Slovakia (SK)
      Sunitinib Krka 50 mg tvrdé kapsuly
    • France (FR)
    • Slovenia (SI)
      Sunitinib Krka 50 mg trde kapsule
    • Sweden (SE)
    • Croatia (HR)
      Sunitinib Krka 50 mg tvrde kapsule
许可日期2021/04/23
最近更新日期2024/10/30
药物ATC编码
    • L01XE04 sunitinib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase